Found: 10
Select item for more details and to access through your institution.
CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.
- Published in:
- Clinical & Experimental Metastasis, 2008, v. 25, n. 2, p. 139, doi. 10.1007/s10585-007-9132-4
- By:
- Publication type:
- Article
Characterization of two Segregation Distorter revertants: Evidence that the tandem duplication is...
- Published in:
- Genetics, 1994, v. 136, n. 1, p. 209, doi. 10.1093/genetics/136.1.209
- By:
- Publication type:
- Article
Population genetics of tandem repeats in centromeric heterochromatin: Unequal crossing over and...
- Published in:
- Genetics, 1993, v. 135, n. 2, p. 477, doi. 10.1093/genetics/135.2.477
- By:
- Publication type:
- Article
Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Resolving the daratumumab interference with blood compatibility testing.
- Published in:
- Transfusion, 2015, v. 55, n. 6pt2, p. 1545, doi. 10.1111/trf.13069
- By:
- Publication type:
- Article
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy.
- Published in:
- Transfusion, 2015, v. 55, n. 6pt2, p. 1555, doi. 10.1111/trf.13150
- By:
- Publication type:
- Article
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 7, p. 1231, doi. 10.1016/j.molonc.2014.03.016
- By:
- Publication type:
- Article
Transfusion management in the era of magrolimab (Hu5F9‐G4), an anti‐CD47 monoclonal antibody therapy.
- Published in:
- Transfusion, 2023, v. 63, n. 12, p. 2377, doi. 10.1111/trf.17597
- By:
- Publication type:
- Article
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0119-4
- By:
- Publication type:
- Article